Drug Oral Care Spray Recalled for Manufacturing Practice Deviations
StellaLife VEGA Oral Care Spray is being recalled for manufacturing deviations. The product was distributed nationwide; consumers should discontinue use of affected lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary precautionary recall due to manufacturing practice deviations with no reported illnesses or injuries. It meets the Moderate severity criterion for voluntary recalls without confirmed harm.
Plain-English summary
StellaLife VEGA Oral Care Spray (1 fl oz/30 ml tubes, peppermint flavor), manufactured by Homeocare Laboratories, Inc., is being recalled due to manufacturing practice deviations. The spray is an over-the-counter oral care product.
The product was distributed throughout the United States. Affected lots are #2407 (expiration February 2024), #2409A (expiration April 2024), and #2409B (expiration May 2024). A total of 33,109 tubes were distributed.
Consumers who have purchased this product should discontinue use immediately. The manufacturer voluntarily initiated the recall on June 5, 2023. For questions or to report adverse events, contact the manufacturer.
The recalled product
- Product
- STELLALIFE VEGA ORAL CARE (SPRAY)
- Brand
- STELLALIFE VEGA ORAL CARE
- Manufacturer
- Homeocare Laboratories, Inc.
- Category
- Drug — Oral Care
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #2407
- exp. date Feb-24
- 2409A
- exp. date Apr-24
- 2409B
- exp. date May-24
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · STELLALIFE VEGA ORAL CARE
- SevereStellaLife VEGA Oral Care Spray Recalled for Bacillus Contamination
FDA (Drugs) · 2024-07-24
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27